Display Settings:

Format

Send to:

Choose Destination

    Clin Infect Dis. 2001 Oct 15;33(8):e91-2. Epub 2001 Sep 20.

    Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.

    van Praag RM, van Heeswijk RP, Jurriaans S, Lange JM, Hoetelmans RM, Prins JM.

    National Aids Therapy Evaluation Center, Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, University of Amsterdam, Amsterdam, The Netherlands.

    The male genital tract is considered an anatomical reservoir during therapy for human immunodeficiency virus infection, because the blood-testis barrier may prevent antiretroviral drugs (e.g., the protease inhibitors ritonavir, saquinavir and nelfinavir) from entering the male genital tract. To our knowledge, there are currently no available data on the penetration of the nucleoside analogue abacavir into the male genital tract. Our report shows that abacavir has good penetration into the male genital tract.

    PMID: 11565093 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information

    • Ritonavir (Norvir®, Norvir® Softgel)

      Ritonavir is used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called protease (pro' tee ace) inhibitors, which slow the spread of HIV infection in the body. It is usually taken w...

    • Saquinavir (Invirase®, Fortovase®)

      Saquinavir is used in combination with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). Saquinavir is in a class of antiviral ...

    • Nelfinavir (Viracept®)

      Nelfinavir is used in combination with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). Nelfinavir is one of a class of medica...

    • » See all 4 drug reports ...